What Are Benign Lung Nodules and Benign Lung Tumors? A nodule is a "spot on the lung," seen on an X-ray or computed tomography (CT) scan. In fact, a nodule shows up on about one in every 500 chest ...
Add Yahoo as a preferred source to see more of our stories on Google. Picture this: Your doctor orders an imaging test like a chest X-ray in preparation for an upcoming procedure, and the results show ...
A new study of more than 10,000 non-smoking adults found that solid lung nodules were present in a considerable portion of study participants. Non-smokers are traditionally thought to be at low risk ...
Lung nodules are clusters of cells found during an x-ray or CT scan that appear as more dense or white spots in the lungs. They might surprise you because lung nodules generally do not cause symptoms, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A greater proportion of men vs. women nonsmokers had a ...
OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...
An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results. Results ...
Dr. Russell Hardie with the Department of Electrical and Computer Engineering has been awarded an National Institutes of Health (NIH) grant to harness artificial intelligence (AI) to revolutionize the ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released ...
InvestorsHub on MSN
BioAffinity launches large-scale clinical study for lung cancer detection technology
Affinity Technologies (NASDAQ:BIAF) announced on March 10, 2026, the launch of a large longitudinal clinical study involving 2,000 patients to evaluate the performance of its CyPath® Lung technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results